| SCHRODER ISF US SMALL & MID-CAP EQUITY A1 ACC USD | RVI USA SMALL/MID CAP | 28,47% | 29,94% | 25,24% | 99,63% |
| AB SICAV I-INTERNATIONAL HEALTH CARE PORTFOLIO C EUR | SALUD | -0,67% | -1,54% | 15,49% | 99,59% |
| GOLDMAN SACHS EMERGING MARKETS EQUITY INCOME X CAP USD | RVI EMERGENTES | 48,90% | 76,29% | 33,32% | 99,58% |
| BGF EUROPEAN EQUITY TRANSITION A2 EUR | RVI EUROPA | 18,33% | 31,81% | 29,67% | 99,55% |
| JPM EUROPE EQUITY ABSOLUTE ALPHA A (PERF) (ACC) USD (HEDGED) | GESTIÓN ALTERNATIVA | 6,55% | 39,08% | 78,26% | 99,55% |
| UNICAJA RENTA VARIABLE ESPAÑA, FI A | RV ESPAÑA | 27,43% | 80,73% | 101,54% | 99,55% |
| INVESCO PAN EUROPEAN EQUITY C CAP EUR | RVI EUROPA | 26,98% | 37,72% | 62,37% | 99,49% |
| UBAM - SWISS EQUITY UHC EUR | RVI EUROPA | 14,27% | 27,72% | 16,64% | 99,47% |
| AB SICAV I-EUROZONE GROWTH PORTFOLIO S1X USD | RV EURO | 14,05% | 25,78% | 32,64% | 99,46% |
| BGF EURO-MARKETS D4 GBP | RV EURO | 13,15% | 35,03% | 37,74% | 99,46% |
| BGF EUROPEAN SPECIAL SITUATIONS A2 USD (HEDGED) | RVI EUROPA CRECIMIENTO | 1,24% | 6,07% | 18,18% | 99,45% |
| NATIXIS ASIA EQUITY I/A (EUR) | RVI ASIA EX-JAPÓN | 50,09% | 59,82% | 14,83% | 99,44% |
| JANUS HENDERSON HF - JAPANESE SMALLER COMPANIES A2 JPY | RVI JAPÓN SMALL/MID CAP | 25,00% | 36,80% | 30,44% | 99,42% |
| BGF JAPAN SMALL & MIDCAP OPPORTUNITIES A2 USD | RVI JAPÓN SMALL/MID CAP | 29,90% | 59,31% | 34,09% | 99,41% |
| INVESCO NASDAQ BIOTECH UCITS ETF ACC | BIOTECNOLOGÍA | 37,81% | 47,88% | 24,26% | 99,41% |
| ALKEN FUND - ABSOLUTE RETURN EUROPE US1 | RETORNO ABSOLUTO | 12,35% | 45,55% | 83,39% | 99,37% |
| TEMPLETON ASIAN GROWTH A (ACC) CZK-H1 | RVI ASIA EX-JAPÓN | 49,31% | 56,11% | 13,48% | 99,33% |
| BLUENOTE GLOBAL EQUITY, FI | RVI GLOBAL | 10,80% | 29,67% | 47,71% | 99,31% |
| DWS INVEST ESG QI LOWVOL WORLD FCH (P) EB | RVI GLOBAL | 12,09% | 36,94% | 39,64% | 99,26% |
| PICTET - PACIFIC EX JAPAN INDEX P EUR | RVI ASIA EX-JAPÓN | 23,90% | 33,16% | 32,68% | 99,26% |
